Novatek International is very pleased to announce that it has successfully met the compliance assessment audit requirements performed by Revance Therapeutics, Inc. for their California-based manufacturing site. In addition, Revance has selected Novatek’s Environmental Monitoring, Utility Monitoring, and Nova-Stability for use at their manufacturing facilities.
The audit ensured that the procedures and practices used by Novatek International to develop, test, install, and validate meets Revance’s mission for critical regulatory software supporting their cGMP and laboratory best practices.
Novatek software products are used at number of FDA, EMEA, Health Canada, TGA approved manufacturing facilities in the US, and more than 30 countries around the world. We are so proud to welcome Revance to Novatek’s client portfolio .
Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation investigational neuromodulator product, DaxibotulinumtoxinA for Injection. We are building a premium category in facial aesthetics, focused on differentiated and improved outcomes, a compelling value proposition and an elevated experience for physicians and patients.